The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1
Category: News
The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until […]
The lifelong autoimmune disease affects more than 150,000 people living in the UK
The conference will take place on 23 to 24 October at Vienna AirportCity
JHU083 reduced tumour growth and triggered tumour cell death in mice
High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours
The partnership will provide six MRC clinical fellows with industry placement opportunities
Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually
The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines
The funding aims to reduce health inequalities in these groups and save more lives